Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Despite major investors selling off shares, ResMed reported a 92.7% jump in earnings per share.
California Public Employees Retirement System (CalPERS) and other institutional investors have sold shares of medical device company ResMed Inc. (RMD), reducing their stakes.
Despite these sales, ResMed reported strong earnings, with a 92.7% increase in earnings per share to $2.43, surpassing estimates.
The company has a market capitalization of $32.62 billion and a "Moderate Buy" rating from analysts.
7 Articles
A pesar de los grandes inversores que venden acciones, ResMed reportó un incremento del 92,7% en ganancias por acción.